Viewing nowCombinationTrubudy Tablets 10/30 Milligrams (Dapagliflozin, Pioglitazone)
Dapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 202302548 · Approved 2023.08.29 · Insurance code 641908300
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in combination with dapagliflozin and pioglitazone to assist in blood sugar control for patients with type 2 diabetes. It is administered to patients adhering to dietary and exercise regimens to enhance blood sugar management effectiveness. This medication helps patients stabilize their blood sugar levels more reliably.
Take this medicine once daily, one tablet at a time, regardless of meals. Do not split the tablet. For patients whose blood glucose is not adequately controlled with metformin and dapagliflozin, the recommended starting dose of this medicine is dapagliflozin 10mg/pioglitazone 15mg once daily. This medicine may be increased to 10/30mg once daily according to tolerability and glycemic response. Patients switching to this medicine from combination therapy with dapagliflozin and pioglitazone should take their previous doses. Assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment based on renal function is necessary when the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or higher. Do not administer this medicine when the eGFR is less than 45mL/min/1.73m2.
This medication may cause or worsen heart failure in patients with impaired heart function; therefore, patients should seek immediate medical attention if symptoms of heart failure, weight changes, dyspnea, or edema occur. Patients with heart failure symptoms or a history of heart failure should not use this medication. This medication can lead to fluid retention, exacerbating heart failure; thus, caution should be exercised by patients with heart disease or edema. Patients with bladder cancer or a history of bladder cancer should not take this medication, and if symptoms such as hematuria or urination difficulties appear, they must inform their physician immediately. Patients with severely impaired liver function or significantly reduced kidney function, particularly those undergoing dialysis, should not use this medication. Patients with diabetic ketoacidosis, Type 1 diabetes, or those with severe infections, trauma, or undergoing surgery are also unsuitable for this medication. Women who are pregnant or may become pregnant should not use this medication, and those with hereditary lactose intolerance should use caution. This medication may lower blood pressure or worsen kidney function; hence, elderly patients with impaired kidney function or those taking diuretics should be closely monitored for blood pressure and kidney function before and after administration. Various adverse reactions, including symptoms of hypoglycemia, infection, edema, weight gain, dizziness, dyspepsia, etc., may occur during the course of taking this medication; patients should consult their physician or pharmacist if these symptoms arise. Particularly due to the risk of hypoglycemia, caution is advised when taking this medication in combination with other hypoglycemic agents such as insulin or sulfonylureas. This medication may cause weight gain and edema, and if significant edema or heart failure symptoms occur, treatment adjustment may be necessary. If liver function abnormalities are present, regular liver function tests should be conducted, and if symptoms of liver damage (fatigue, loss of appetite, jaundice, etc.) arise, they should inform their physician immediately. This medication can affect blood test results, so regular testing is required. During treatment, infections, especially genital and urinary tract infections, may occur, so maintaining cleanliness is crucial; immediate treatment should be sought if any infection symptoms arise.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. Additionally, it is important to store the medication at room temperature between 1°C and 30°C. This helps maintain the drug's effectiveness and safety.
White and light yellow, double convex, octagonal biconvex tablets
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YuYoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Hanmi Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.